VTVT ▲ +1.2% - vTv Therapeutics Inc.
$VTVT - vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
05-OCT-2026 08:01 AM ET
Share this post
More filings for $VTVT
VTVT ▼ -3.1% - vTv Therapeutics Inc.Sep 15, 2026VTVT ▼ -0.4% - vTv Therapeutics Inc.Sep 2, 2026$VTVT SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026
View full $VTVT filing history →💬 Comments
Loading comments…
Leave a comment